分子藥理學(xué)歡迎報(bào)告藥物作用或分子水平選擇性毒性新信息的手稿供審議。編輯們鼓勵(lì)投稿闡明分子機(jī)制。這些可能包括，例如，受體、信號(hào)、途徑、酶、通道和轉(zhuǎn)錄機(jī)制的研究。同時(shí)，也鼓勵(lì)報(bào)告開(kāi)發(fā)具有廣泛適用性或產(chǎn)生新分子見(jiàn)解的新試劑或新技術(shù)的研究。雖然分子藥理學(xué)試圖發(fā)表具有很強(qiáng)的生物實(shí)驗(yàn)成分的研究，該雜志也歡迎涉及與藥物設(shè)計(jì)或藥物作用相關(guān)的分子建模的研究。

Molecular Pharmacology welcomes manuscripts for consideration that report new information on drug action or selective toxicity at the molecular level. The Editors encourage submissions that shed light upon molecular mechanisms. These may include, for example, studies of receptors, signaling, pathways, enzymes,channels, and transcriptional mechanisms. Studies that report the development of novel reagents or technologies that are of broad applicability or yield new molecular insights are also encouraged. While Molecular Pharmacology attempts to publish studies with a strong component of biological experimentation, the journal also welcomes studies that involve molecular modeling relevant to drug design or drug action.